GSK plc (LSE/NYSE: GSK) today announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications:
On December 10, 2025, the U.S. House of Representatives passed the National Defense Authorization Act for Fiscal Year 2026 (the NDAA). The NDAA is a broad policy bill that authorizes spending levels, policies, and authorities for key military and…
Amazon shareholder resolution targets AI work with Israel | The Jerusalem PostJerusalem Post/Business & InnovationThe resolution asks Amazon’s board to identify “instances of misalignment” between its internal standards and sales of…
December 15, 2025
Highlighting its nationally recognized achievements in…
SAN ANTONIO – The Bexar County Medical Examiner’s Office is asking for…
Attorney General Ken Paxton has filed suit against five major television companies for spying on Texans by secretly recording what consumers watch in their own homes. The five major corporations being sued are as…
12/15/2025
As we look back on 2025, it’s clear that the internet as we know it is changing. Technology-enabled access to knowledge should be flourishing. Instead, information is being removed from the web or locked away in walled gardens. We are…
December 15, 2025 – Calgary, Alberta
Today, the Honourable Julie Dabrusin, Minister of the Environment, Climate Change and Nature, marks the 30th anniversary of the Environmental Damages Fund by announcing that the Government of Canada…